Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Apr;30(2):144-9.
doi: 10.4103/0970-1591.126887.

Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression?: A prospective study

Sanjoy Kumar Sureka  1 , Vinita Agarwal  2 , Shalini Agnihotri  1 , Rakesh Kapoor  1 , Aneesh Srivastava  1 , Anil Mandhani  1
Affiliations

Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression?: A prospective study

Sanjoy Kumar Sureka et al. Indian J Urol. 2014 Apr.

Abstract

Purpose: Conventional, transurethral resection of bladder tumor (TURBT) involves piecemeal resection of the tumor and has a very high recurrence rate. We evaluated the outcome of en-bloc TURBT (ET) in comparison with conventional TURBT (CT) in non-muscle invasive bladder carcinoma in terms of recurrencew and progression.

Materials and methods: From September 2007 to June 2011, in a prospective non-randomized interventional setting, ET was compared with CT in patients with solitary tumor of 2-4 cm size in terms of recurrence and progression. Pedunculated tumors, size >4 cm, tumors with associated hydroureteronephrosis and biopsy specimen with absent detrusor muscles were excluded. Fisher's exact test and survival analyses were used to compare the demography and the outcome.

Results: A total of 21 patients of ET were compared with 24 patients of CT. Mean tumor size was 2.8 cm in ET and 3.3 cm in CT group. Location of tumor, stage and grade were comparable in both groups. Recurrence rate was 28.6% versus 62.5% (P = 0.03) and progression rate was 19% versus 33.3% (P = 0.32) in ET versus CT group respectively. Recurrence free survival was 45.1 (95% CI: 19.0-38 months) and 28.5 (95% CI: 35.4-54.7 months) in ET and CT group (P = 0.018). Progression free survival in ET and CT was 48.32 (95% CI: 35.5-53.0 months) and 44.26 (95% CI: 39.0-57.5 months), P = 0.46.

Conclusion: There was a significant reduction in the recurrence rate and time to recurrence with ET. Rate of progression was also relatively less with ET, though not statistically significant.

Keywords: Bladder cancer; detrusor muscles; non-muscle invasive bladder cancer; progression free survival; recurrence free survival.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Graph 1
Graph 1
Study population
Figure 1
Figure 1
Angle of the loop electrode was changed manually from 90° to 45° for en-bloc transurethral resection of bladder tumor
Figure 2
Figure 2
Recurrence free survival
Figure 3
Figure 3
Progression free survival
Figure 4
Figure 4
En-bloc resection provides a tissue piece of the bladder with all the layers in contiguity to assess the T stage and margin status. In inset, a 3 cm tumor removed en-bloc
See this image and copyright information in PMC

References

    1. Grasso M. Bladder cancer: a major public health issue. Eur Urol Suppl. 2008;7:510–15.
    1. Raina V, Tyagi BB, Manoharan N. New Delhi: Delhi Cancer Registry, Dr. B.R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences; 2007. Mar, Cancer Incidence and Mortality in Delhi UT-Urban, 2002-2003.
    1. Gupta P, Jain M, Kapoor R, Muruganandham K, Srivastava A, Mandhani A. Impact of age and gender on the clinicopathological characteristics of bladder cancer. Indian J Urol. 2009;25:207–10. - PMC - PubMed
    1. Brausi M, Collette L, Kurth K, van der Meijden AP, Oosterlinck W, Witjes JA, et al. Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies. Eur Urol. 2002;41:523–31. - PubMed
    1. Mariappan P, Smith G, Lamb AD, Grigor KM, Tolley DA. Pattern of recurrence changes in noninvasive bladder tumors observed during 2 decades. J Urol. 2007;177:867–75. - PubMed